Ennogen Holdings Limited
Registered name: ENNOGEN HOLDINGS LIMITED
Ennogen Holdings Limited made £1.4m profit in the year to 31 Dec 2025 (revenue not disclosed).
Ennogen Holdings Limited reported £1.4m profit in the year to 31 Dec 2025, up 6175% on the year before; its revenue was not disclosed. It had 0 employees. The company is classified under “activities of other holding companies” and is based in Dartford; we hold 5 years of its filed accounts.
- Status
- Active
- Location
- Dartford, South East
- Age
- 5 yrs · since 2021
- Type
- Private Limited Company
Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.
Key figures
This company published its profit but not its turnover, so revenue and margins are not disclosed. We never estimate them.
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2021 | 31 Dec 2022 | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Profit only | Profit only | Profit only |
| Profit & loss | |||||
| Revenue (turnover) | £24.1m | £25.6m | — | — | — |
| Cost of sales | £15.6m | £8.2m | — | — | — |
| Gross profit | £8.4m | £17.3m | — | — | — |
| Operating profit | £507k | £7.9m | — | — | — |
| Profit before tax | £500k | £71.4m | — | — | — |
| Profit after tax | £775k | £71.4m | £15.4k | £22.9k | £1.4m |
| Profit (best available) | £775k | £71.4m | £15.4k | £22.9k | £1.4m |
| Staff costs | £2.1m | £2.9m | — | — | — |
| Employees (average) | 38 | 41 | 0 | 0 | 0 |
| Ratios | |||||
| Profit margin | 3.2% | 279.1% | — | — | — |
| Gross margin | 35.1% | 67.8% | — | — | — |
| Revenue per employee | £633k | £624k | — | — | — |
| Profit per employee | £20.4k | £1.7m | — | — | — |
| Cash conversion | 1505% | 135.6% | — | — | — |
| Growth (year on year) | |||||
| Revenue growth | — | ▲6.3% | — | — | — |
| Profit growth | — | ▲9106% | ▼100% | ▲48.3% | ▲6175% |
| Headcount growth | — | ▲7.9% | ▼100% | — | — |
| Balance sheet — indirect signals, not revenue | |||||
| Cash at bank | £8m | £9.5m | £2.8k | £47.7k | £233k |
| Net assets | £50.3k | £71.4m | £71.4m | £71.6m | £71.7m |
| Fixed assets | £7m | £13.3m | £71.4m | £71.6m | £74.8m |
| Current assets | £21.9m | £24.5m | £103k | £243k | £1.7m |
| Debtors | £50k | £50k | £0 | £0 | £0 |
| Deferred income | — | — | £52k | £39.2k | £51.4k |
| Cash from operations | £7.6m | £10.7m | — | — | — |
| Source | Accounts · bulk data Dec 2023 | Accounts · bulk data Dec 2023 | FullAccounts · bulk data Sep 2025 | FullAccounts · bulk data Sep 2025 | FullAccounts · bulk data Jun 2026 |
How the business works
- Profit margin
- —
- Profit ÷ revenue.
- Gross margin
- —
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- —
- Revenue ÷ average employees.
- Profit per employee
- —
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲0%
- Now £71.7m
- Cash at bank
- ▲390%
- Now £233k
- Headcount
- —
- Now 0
- Deferred income
- ▲31%
- Now £51.4k
- Fixed assets
- ▲5%
- Now £74.8m
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Subsidiaries (3)
- Ennogen Healthcare LtdRev. — · Profit £1.1m
- Ennogen Investments LtdRev. — · Profit −£3k
- Ennogen Pharma LtdRev. — · Profit £603k
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £1.4m), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.